Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Rosso Felipe

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Annals of Translational Medicine|November 4, 2020
Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapyVivian Bonezi, Fabiana Dalla Vecchia Genvigir, Patrícia de Cássia Salgado, et al.
Frontiers in Pharmacology|November 30, 2018
Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant RecipientsAntony Brayan Campos-Salazar, Fabiana Dalla Vecchia Genvigir, Claudia Rosso Felipe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2020
Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin without CMV prophylaxis - a cohort single-center studyMayara Ivani de Paula, Mary Grace Bowring, Ashton A Shaffer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 7, 2019
Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donorAlexandra Nicolau Ferreira, Claudia Rosso Felipe, Marina Cristelli, et al.
Jornal Brasileiro De Nefrologia|January 11, 2018
The current burden of cytomegalovirus infection in kidney transplant recipients receiving no pharmacological prophylaxisClaudia Rosso Felipe, Alexandra Nicolau Ferreira, Adrieli Bessa, et al.
Pharmacogenomics|December 19, 2019
<i>CYP3A5*3</i> and <i>CYP2C8*3</i> variants influence exposure and clinical outcomes of tacrolimus-based therapyFabiana Dalla Vecchia Genvigir, Antony Brayan Campos-Salazar, Claudia Rosso Felipe, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2018
The effect of anti-thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxisGeovana Basso, Claudia Rosso Felipe, Marina Pontello Cristelli, et al.
Epigenomics|December 4, 2020
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot studyRenata Caroline Costa Freitas, Raul Hernandes Bortolin, Fabiana Dalla Vecchia Genvigir, et al.
Jornal Brasileiro De Nefrologia|March 31, 2011
[Alemtuzumab induction in kidney transplant recipients]Edison Luiz Mandia Sampaio, Tainá Veras de Sandes Freitas, Nelson Zocoler Galante, et al.
Clinical Transplantation|August 11, 2019
Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experimentMarina Pontelo Cristelli, Claudia Rosso Felipe, Paulo Sergio de Souza Prizmic, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Annals of Translational Medicine|November 4, 2020
Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapyVivian Bonezi, Fabiana Dalla Vecchia Genvigir, Patrícia de Cássia Salgado, et al.
Frontiers in Pharmacology|November 30, 2018
Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant RecipientsAntony Brayan Campos-Salazar, Fabiana Dalla Vecchia Genvigir, Claudia Rosso Felipe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2020
Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin without CMV prophylaxis - a cohort single-center studyMayara Ivani de Paula, Mary Grace Bowring, Ashton A Shaffer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 7, 2019
Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donorAlexandra Nicolau Ferreira, Claudia Rosso Felipe, Marina Cristelli, et al.
Jornal Brasileiro De Nefrologia|January 11, 2018
The current burden of cytomegalovirus infection in kidney transplant recipients receiving no pharmacological prophylaxisClaudia Rosso Felipe, Alexandra Nicolau Ferreira, Adrieli Bessa, et al.
Pharmacogenomics|December 19, 2019
<i>CYP3A5*3</i> and <i>CYP2C8*3</i> variants influence exposure and clinical outcomes of tacrolimus-based therapyFabiana Dalla Vecchia Genvigir, Antony Brayan Campos-Salazar, Claudia Rosso Felipe, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2018
The effect of anti-thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxisGeovana Basso, Claudia Rosso Felipe, Marina Pontello Cristelli, et al.
Epigenomics|December 4, 2020
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot studyRenata Caroline Costa Freitas, Raul Hernandes Bortolin, Fabiana Dalla Vecchia Genvigir, et al.
Jornal Brasileiro De Nefrologia|March 31, 2011
[Alemtuzumab induction in kidney transplant recipients]Edison Luiz Mandia Sampaio, Tainá Veras de Sandes Freitas, Nelson Zocoler Galante, et al.
Clinical Transplantation|August 11, 2019
Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experimentMarina Pontelo Cristelli, Claudia Rosso Felipe, Paulo Sergio de Souza Prizmic, et al.
Pageof 4